Group Photo of International Collaborators with the London School of Hygiene and Tropical Medicine Team members at meeting held at Hilton Euston hotel 21-22nd September 2016.
Professor Zahida Qureshi the Principal Investigator of the WOMAN Trial in KENYA participated in the “The Woman Trial Writing Committee Meeting” held in London 21-22nd September 2016.
The WOMAN trial was testing whether tranexamic acid, a blood clot stabiliser that was discovered in Japan in the 1950’s, can become an essential tool for fighting excessive bleeding soon after giving birth “Postpartum Haemorrhage”, which is the is the number one cause of maternal deaths around the world, particularly in low and middle income countries.
The World Maternal Antifibrinolytic Trial (Woman Trial) coordinated by the London School of Hygiene & Tropical Medicine (LSHTM) Clinical Trials Unit (CTU) was an international clinical trial of the effect of Tranexamic Acid on death, hysterectomy and other maternal outcomes, in women with PPH.14 It began in March 2010 and completed patient enrollment in April 2016.
Globally the trial recruited 20,060 participants from 200 sites located in 21 countries.
In Kenya Professor Qureshi as the Country Principal Investigator worked with nine Hospitals which were:-
- Kenyatta National Hospital
- AIC Kijabe Mission Hospital
- BungomaLevel 4 Hospital
- Coast General Teaching and Referral Level 5 hospital
- Garissa Level 4 hospital
- Mwingi Level 4 hospital
- Nakuru Level 5 Hospital
- The Nairobi Hospital
- MoiTeaching and Referral Hospital
The trial writing committee discussed the preliminary findings of the trial and it is hoped that by late 2016 the results of this very important trial will be released.